HCW Biologics (HCWB) Invested Capital (2022 - 2025)

HCW Biologics (HCWB) has 4 years of Invested Capital data on file, last reported at $6.8 million in Q4 2025.

• Quarterly Invested Capital rose 7.83% year-over-year to $6.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.3 million (up 103.64% YoY) and the FY2025 annual result came in at $6.8 million, up 7.83% from the prior year.
• Invested Capital steadied at $6.8 million in Q4 2025, from $6.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $38.3 million in Q4 2022 to a low of $67979.0 in Q1 2023.
• A 4-year average of $6.5 million and a median of $6.3 million in 2024 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2024 — Invested Capital jumped 5287.93% — and 2025, when it gained 7.36%.
• Tracing HCWB's Invested Capital over 4 years: stood at $38.3 million in 2022, then plunged by 99.69% to $117680.0 in 2023, then soared by 5265.98% to $6.3 million in 2024, then rose by 7.83% to $6.8 million in 2025.
• The last three Invested Capital figures came in at $6.8 million (Q4 2025), $6.8 million (Q3 2025), and $6.4 million (Q2 2025), per Business Quant data.